Securities Registration: Employee Benefit Plan (s-8)
November 10 2022 - 4:35PM
Edgar (US Regulatory)
As filed with the Securities and Exchange
Commission on November 10, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
THE
SECURITIES ACT OF 1933
Science
37 Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or other jurisdiction of incorporation or
organization) |
84-4278203
(I.R.S. Employer Identification No.) |
800 Park Offices Drive, Suite 3606
Research Triangle Park, NC 27709
(Address of principal executive offices) (Zip code)
Science 37 Holdings, Inc. 2022 Employment Inducement
Incentive Award Plan
(Full title of the plan)
Christine Pellizzari
800 Park Offices Drive, Suite 3606
Research Triangle Park, NC 27709
(Name and address of agent for service)
(984) 377-3737
(Telephone number, including area code, of agent
for service)
Copies to:
Ryan J. Maierson
Thomas G. Brandt
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, TX 77002
(713) 546-7000
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
¨ |
|
Accelerated filer |
¨ |
Non-accelerated filer |
x |
|
Smaller reporting company |
x |
|
|
|
Emerging growth company |
x |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
This Registration Statement
on Form S-8 is being filed by Science 37 Holdings, Inc. (the “Registrant”) to register an aggregate 1,000,000 shares of the
Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), reserved for issuance under the Registrant’s
2022 Employment Inducement Incentive Award Plan, to be granted to certain eligible individuals as a material inducement to his or her
entering into employment with the Registrant or its subsidiaries.
PART I
INFORMATION
REQUIRED IN THE SECTION 10(a) PROSPECTUS
Not required to be filed with this Registration
Statement on Form S-8 (this “Registration Statement”) in accordance with the rules and regulations of the U.S. Securities
and Exchange Commission (the “Commission”).
| Item 2. | Registrant Information and
Employee Plan Annual Information. |
Not required to be filed with this Registration
Statement in accordance with the rules and regulations of the Commission.
PART II
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
References in this Registration
Statement to “we,” “us,” “our,” and the “Registrant,” or similar references, refer to
Science 37 Holdings, Inc. unless otherwise stated or the context otherwise requires.
| Item 3. | Incorporation of Documents
by Reference. |
The following documents, which
have been filed by the Registrant with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), are incorporated by reference in, and shall be deemed to be a part of, this Registration Statement:
(a) the
Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Commission on March 22, 2022 (File No. 001-39727);
(b) the
Registrant’s Definitive Proxy Statement on Schedule 14A filed with the Commission on March 23, 2022;
(c) the
Registrant’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30,
2022, filed with the Commission on May 9, 2022, August 11, 2022
and November 10, 2022, respectively (File No. 001-39727);
(d)
the Registrant’s Current Reports on Form 8-K filed with the Commission on May 13, 2022, September 12, 2022, September 30, 2022 and October 5, 2022; and
(e) the
description of the Registrant’s securities contained in the Registrant’s Registration Statement on Form 8-A, filed with
the Commission on November 19, 2020 (File 001-39727), including any amendments or reports filed for the purpose of updating such description.
All reports and other documents
filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date hereof
and prior to the filing of a post-effective amendment which indicates that all securities offered pursuant to this Registration Statement
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to
be a part hereof from the date of filing of such documents or reports.
For purposes of this Registration
Statement, any document or any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be
deemed to be modified or superseded to the extent that a subsequently filed document or a statement contained therein, or in any other
subsequently filed document which also is or is deemed to be incorporated by reference, modifies or supersedes such document or such statement
in such document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part
of this Registration Statement.
Under
no circumstances shall any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference
unless such Form 8-K expressly provides to the contrary.
| Item 4. | Description of Securities. |
Not applicable.
| Item 5. | Interests of Named Experts
and Counsel. |
Not applicable.
| Item 6. | Indemnification of Directors
and Officers. |
Section 102 of the General
Corporation Law of the State of Delaware (the “DGCL”) permits a corporation to eliminate the personal liability of directors
of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where
the director breached such director’s duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly
violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained
an improper personal benefit. Our restated certificate of incorporation provides that no director of the Registrant shall be personally
liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of
law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for
breaches of fiduciary duty.
Section 145 of the DGCL
provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation, or any other person
serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities
against all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
by the person in connection with an action, suit or proceeding to which such person was or is a party or is threatened to be made a party
to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in
a manner such person reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action
or proceeding, had no reasonable cause to believe such person’s conduct was unlawful, except that, in the case of actions brought
by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person
shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating
court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly
and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
Our bylaws provide that we
will indemnify and hold harmless, to the fullest extent permitted by the DGCL, each person who was or is a party or threatened to be made
a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us) by reason of
the fact that such person is or was a director or officer, or is or was serving at our request as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or enterprise (all such persons being referred to as an “Indemnitee”),
against all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
in connection with such action, suit or proceeding, if such Indemnitee acted in good faith and in a manner such Indemnitee reasonably
believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, such Indemnitee had
no reasonable cause to believe such Indemnitee’s conduct was unlawful. Our bylaws provide that we will indemnify any Indemnitee
who was or is a party or threatened to be made a party to any threatened, pending or completed action or suit by or in the right of us
to procure a judgment in our favor by reason of the fact that the Indemnitee is or was a director or officer, or is or was serving at
our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or enterprise, against
all expenses (including, attorneys’ fees) actually and reasonably incurred in connection with such action or suit, if the Indemnitee
acted in good faith and in a manner such Indemnitee reasonably believed to be in, or not opposed to, our best interests, except that no
indemnification shall be made with respect to any claim, issue or matter as to which such Indemnitee shall have been adjudged to be liable
to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, such Indemnitee is entitled
to indemnification of such expenses.
We have entered into indemnification
agreements with each of our directors and officers. These indemnification agreements, among other things, require us to indemnify each
director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys’
fees, judgments, penalties fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including
any action or proceeding by or in right of us, arising out of the person’s services as a director or executive officer.
We maintain a general liability
insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions
in their capacities as directors or officers.
| Item 7. | Exemption from Registration
Claimed. |
Not applicable.
The following documents are filed as exhibits to
this Registration Statement:
(a) The
undersigned Registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes
in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation
of Registration Fee” table in the effective registration statement;
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or
any material change to such information in the Registration Statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of
this section do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective
amendment by those paragraphs is contained in periodic reports filed by or furnished to the Commission by the Registrant pursuant to Section 13
or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
(2) That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.
(3) To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
(b) The
undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the
Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable,
each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated
by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered herein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in Research Triangle Park, State of North Carolina, on November 10, 2022.
|
SCIENCE 37 Holdings, Inc. |
|
|
|
|
|
By: |
/s/ David Coman |
|
|
Name: |
David Coman |
|
|
Title: |
Chief Executive Officer |
SIGNATURES AND POWER OF ATTORNEY
Each
person whose signature appears below constitutes and appoints each of David Coman and Mike Zaranek, acting alone or together with another
attorney-in-fact, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such
person and in his or her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective
amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith,
with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each
and every act and thing requisite or necessary to be done in and about the premises, as fully and to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ David Coman |
|
Chief Executive Officer and Director |
|
November 10, 2022 |
David Coman |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Mike Zaranek |
|
Chief Financial Officer (Principal Financial Officer and Principal |
|
November 10, 2022 |
Mike Zaranek |
|
Accounting Officer) |
|
|
|
|
|
|
|
/s/ John W. Hubbard |
|
Director |
|
November 10, 2022 |
John W. Hubbard |
|
|
|
|
|
|
|
|
|
/s/ Neil Tiwari |
|
Director |
|
November 10, 2022 |
Neil Tiwari |
|
|
|
|
|
|
|
|
|
/s/ Robert Faulkner |
|
Director |
|
November 10, 2022 |
Robert Faulkner |
|
|
|
|
|
|
|
|
|
/s/ Paul von Autenried |
|
Director |
|
November 10, 2022 |
Paul von Autenried |
|
|
|
|
|
|
|
|
|
/s/ Bhooshitha B. De Silva |
|
Director |
|
November 10, 2022 |
Bhooshitha B. De Silva |
|
|
|
|
|
|
|
|
|
/s/ Emily Rollins |
|
Director |
|
November 10, 2022 |
Emily Rollins |
|
|
|
|
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Sep 2023 to Sep 2024